PHARMACOVIGILANCE

Serious side effects force a third of diabetics to quit...

  The side effects of the world's most commonly-prescribed diabetes drug are so severe that around a third of patients stop taking it, a new study has...

Half of over-65s taking five or more prescription drugs a...

Half the population of over-65s is taking at least five different prescription drugs every day, and some are taking as many as 23, a new study has discovered. The...

Regulator hid dangers of epilepsy drug for 40 years

    Drug regulators knew an epilepsy drug could cause birth abnormalities if a woman took it while she was pregnant, but didn't alert the public...

Young women still being prescribed thalidomide

Thalidomide, the morning sickness drug that caused appalling birth defects in more than 10,000 babies in the 1960s, is still being prescribed to young women who become pregnant—and three women...

Someone takes a drug wrongly every 21 seconds (that's 10.5...

Pharmaceuticals are dangerous enough as it is—but when they're taken incorrectly, they can be lethal. It's a common problem, with someone in the US reporting a serious medication error every...

Depression overdiagnosed by questionnaire developed by drug company

People are being diagnosed with depression with a simplistic point-scoring questionnaire that was developed by the drug company that has some of the leading antidepressant brands, and so is most...

One in three new drugs have serious—and sometimes deadly—safety issues

There's something seriously wrong with our drug approval processes. One in three drugs that pass all the usual checks before being given a licence are unsafe, and are causing serious—and...

New drugs aren't being properly tested for their safety or...

New 'breakthrough' drugs are often being allowed onto the market as safe and effective treatments with minimal evidence—and drug companies are failing to provide any good research even five years...

Statins raise type 2 diabetes risk by 60 per cent

  Cholesterol-lowering statins do raise the risk of type 2 diabetes, a major new review has confirmed. The risk can rise by as much as 60 per...
Indietro12Avanti
EMA - Events


Events

Paediatric strategy forum for medicinal product development of checkpoint inhibitors...

The third multi-stakeholder Paediatric Strategy Forum, jointly organised by EMA and ACCELERATE will focus on checkpoint inhibitors used in combination therapy, in children and adolescents. This Forum will reviewed the...

Multi-stakeholder workshop to further improve the implementation of the Paediatric...

This workshop, organised by the European Medicines Agency (EMA) and the European Commission, follows the publication of the Commission’s ten-year report on implementation of the Paediatric Regulation and the state...

A common data model in Europe? – Why? Which? How?,...

This meeting will aim to define the opportunities and challenges in applying a common data model in Europe to support regulatory decision-making and agree guiding principles for the development of...
EMA - News and press releases


News and press releases

News and press releases: Committee for Medicinal Products for...

CVMP adopts new guideline on user safety of topically applied veterinary medicines

News and press releases: Eye injuries in people and...

Caution is advised when applying the medicine

News and press releases: Meeting highlights from the Pharmacovigilance...

PRAC starts new referral on methotrexate
EMA - Public consultations


Ongoing public consultations

Scientific guideline: Draft addendum to the guideline on the...

This document proposes the development of an addendum to the Guideline on the evaluation of medicines indicated for treatment of bacterial infections CPMP/EWP/558/95 rev 2), to provide specific guidance on...

Scientific guideline: Public consultation concerning the European Union template...

The aim of this public consultation is to collect relevant information from stakeholders to help the Good manufacturing practice (GMP)/Good distribution practice (GDP) Inspectors Working Group to develop an effective...
EMA - Vacancies


Vacancies

Discontinuation of vacancies RSS feed - visit our Careers section

Please note that from January 2018, EMA will publish vacancy notices on its [email protected] portal and will no longer update this vacancies RSS feed. For more information, please click on...